| mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
1e-06 |
| mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
5e-06 |
| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-06 |
| mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
6e-06 |
| mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
5e-05 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0001 |